$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
他泽司他在河南哪里买的到?肉瘤新药他泽司他效果咋样?
2025-10-19 11:44:20
Check Details
肉瘤新药他泽司他详细介绍!
2025-10-19 11:44:20
Check Details
肉瘤新药-他泽司他(Tazemetostat)
2025-10-19 11:44:20
Check Details
他泽司他治疗上皮样肉瘤的效果怎么样?
2025-10-19 11:44:20
Check Details
肉瘤新药他泽司他获批上市!
2025-10-19 11:44:20
Check Details
他泽司他治疗肉瘤的效果和副作用是什么?
2025-10-19 11:44:20
Check Details
他泽司他可以用医保报销吗?治疗期间需要注意什么?
2025-10-19 11:44:20
Check Details
他泽司他(Tazemetostat)美国获批治疗上皮样肉瘤(ES)
2025-10-19 11:44:20
Check Details
【用药科普】他泽司他的使用方法及副作用
2025-10-19 11:44:20
Check Details
2023CSCO大会指南更新——小圆细胞肉瘤部分更新亮点
2025-10-19 11:44:20
Check Details
2023指南出炉!软骨肉瘤治疗药物汇总
2025-10-19 11:44:20
Check Details
他泽司他用药效果如何?
2025-10-19 11:44:20
Check Details
1
2
...
8
9
10
11
12
13
14
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
2
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
3
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
4
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
5
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
6
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
7
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
8
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
9
Vemurafenib (Zelboraf) Complete Medication Guide
10
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
11
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
12
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options